Estimation of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease

被引:36
|
作者
Spithoven, Edwin M. [1 ]
van Gastel, Maatje D. A. [1 ]
Messchendorp, A. Lianne [1 ]
Casteleijn, Niek F. [1 ]
Drenth, Joost P. H. [2 ]
Gaillard, Carlo A. [1 ]
de Fijter, Johan W. [3 ]
Meijer, Esther [1 ]
Peters, Dorien J. M. [4 ]
Kappert, Peter [5 ]
Renken, Remco J. [6 ]
Visser, Folkert W. [1 ]
Wetzels, Jack F. M. [7 ]
Zietse, Robert [8 ]
Gansevoort, Ron T. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
[3] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands
[4] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands
[8] Erasmus MC, Dept Nephrol, Rotterdam, Netherlands
关键词
Autosomal dominant polycystic kidney disease (ADPKD); total kidney volume (TKV); magnetic resonance imaging (MRI); estimation methods; ellipsoid; PANK; validation; ADPKD; PROGRESSION; TOLVAPTAN; TRIALS; DESIGN;
D O I
10.1053/j.ajkd.2015.06.017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In autosomal dominant polycystic kidney disease (ADPKD), obtaining measured total kidney volume (mTKV) by magnetic resonance (MR) imaging and manual tracing is time consuming. Two alternative MR imaging methods have recently been proposed to estimate TKV (eTKV(ellipsoid) and eTKV(PANK)), which require less time. Study Design: Cross-sectional and longitudinal diagnostic test study. Setting & Participants: Patients with ADPKD with a wide range of kidney function and an approved T2-weighted MR image obtained at the University Medical Centers of Groningen, Leiden, Nijmegen, and Rotterdam, the Netherlands, in 2007 to 2014. Test set for assessing reproducibility, n = 10; cohort for cross-sectional analyses, n = 220; and cohort for longitudinal analyses, n = 48. Index Tests: Average times for eTKV(ellipsoid) and eTKV(PANK) were 5 and 15 minutes, respectively. Bias is defined as (mTKV - eTKV)/mTKV x 100%; precision, as one standard deviation of bias. Reference Tests: mTKV using manual tracing to calculate the area within kidney boundaries times slice thickness. Average time for mTKV was 55 minutes. Results: In the test set, intra- and intercoefficients of variation for mTKV, eTKV(ellipsoid), and eTKV(PANK) were 1.8% and 2.3%, 3.9% and 6.3%, and 3.0% and 3.4%, respectively. In cross-sectional analysis, baseline mTKV, eTKV(ellipsoid), and eTKV(PANK) were 1.96 (IQR, 1.28-2.82), 1.93 (IQR, 1.25-2.82), and 1.81 (IQR, 1.17-2.62) L, respectively. In cross-sectional analysis, bias was 0.02% +/- 3.2%, 1.4% +/- 9.2%, and 4.6% +/- 7.6% for repeat mTKV, eTKV(ellipsoid), and eTKV(PANK), respectively. In longitudinal analysis, no significant differences were observed between percentage change in mTKV (16.7% +/- 17.1%) and percentage change in eTKV(ellipsoid) (19.3% 6 16.1%) and eTKV(PANK) (17.8% +/- 16.1%) over 3 years. Limitations: Results for follow-up data should be interpreted with caution because of the limited number of patients. Conclusions: Both methods for eTKV perform relatively well compared to mTKV and can detect change in TKV over time. Because eTKV(ellipsoid) requires less time than eTKV(PANK), we suggest that this method may be preferable in clinical care. (C) 2015 by the National Kidney Foundation, Inc.
引用
收藏
页码:792 / 801
页数:10
相关论文
共 50 条
  • [31] Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases
    Higashihara, Eiji
    Yamamoto, Kouji
    Kaname, Shinya
    Okegawa, Takatsugu
    Tanbo, Mitsuhiro
    Yamaguchi, Tsuyoshi
    Shigemori, Kaori
    Miyazaki, Isao
    Yokoyama, Kenichi
    Nutahara, Kikuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (01) : 100 - 111
  • [32] Autosomal dominant polycystic kidney disease
    Serra A.L.
    Wüthrich R.P.
    Der Nephrologe, 2007, 2 (6): : 459 - 468
  • [33] Autosomal Dominant Polycystic Kidney Disease
    Perumareddi, Parvathi
    Trelka, Darin P.
    PRIMARY CARE, 2020, 47 (04): : 673 - 689
  • [34] Autosomal dominant polycystic kidney disease
    Kühn W.
    Walz G.
    Der Nephrologe, 2012, 7 (3): : 259 - 268
  • [35] Total kidney volume in autosomal dominant polycystic kidney disease: intraobserver and interobserver agreement of two methods with MRI
    Gundogdu, Elif
    Cihan, Cagatay
    Yazici, Celal
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024, 54 (03) : 537 - 544
  • [36] Effect of everolimus on polycystic liver volume in autosomal dominant polycystic kidney disease
    Zschiedrich, Stefan
    Budde, Klemens
    Walz, Gerd
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (04) : 757 - 758
  • [37] Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan
    Yamaguchi, Tsuyoshi
    Higashihara, Eiji
    Okegawa, Takatsugu
    Miyazaki, Isao
    Nutahara, Kikuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (05) : 1213 - 1223
  • [38] Effect of everolimus on polycystic liver volume in autosomal dominant polycystic kidney disease
    Stefan Zschiedrich
    Klemens Budde
    Gerd Walz
    Clinical and Experimental Nephrology, 2015, 19 : 757 - 758
  • [39] Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
    Messchendorp, A. Lianne
    Casteleijn, Niek F.
    Meijer, Esther
    Gansevoort, Ron T.
    Drenth, Joost P.
    de Fijter, Johan W.
    Peters, Dorien J. M.
    Visser, Folkert W.
    Wetzels, Jack F.
    Zietse, Robert
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (08) : 1306 - 1316
  • [40] The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait
    Ali, Hamad
    Naim, Medhat
    Senum, Sarah R.
    AlSahow, Ali
    Bahbahani, Yousif
    Abu-Farha, Mohamed
    Abubaker, Jehad
    Mohammad, Anwar
    Al-Hunayan, Adel
    Asbeutah, Akram M.
    Zayed, Mohamed
    Devarajan, Sriraman
    Hussain, Naser
    John, Sumi Elsa
    Channanath, Arshad
    Thanaraj, Thangavel Alphonse
    Al-Ali, Mohammad
    AlMousawi, Mustafa
    Al-Mulla, Fahd
    Harris, Peter C.
    CLINICAL KIDNEY JOURNAL, 2023, 16 (02) : 355 - 366